Various
Analyst Upgrades and Downgrades For the Week of May 6th
Analyst upgrades, downgrades, and more
By Justin Nugent · May 6, 2024

Friday, May 10th:
- Upgrades:
- Array Tech (ARRY) – Oppenheimer – Perform>>Outperform – $20
- Dutch Bros (BROS) – TD Cowen – Hold>>Buy – $33>>$46
- Cheesecake Factory (CAKE) – Citigroup – Neutral>>Buy – $38>>$47
- Dominion Energy (D) – BofA Securities – Underperform>>Neutral – $43>>$54
- HBT Financial (HBT) – Raymond James – Mkt Perform>>Outperform – $23
- Lear (LEA) – Morgan Stanley – Equal-Weight>>Overweight – $150>>$160
- 3M (MMM) – HSBC Securities – Hold>>Buy – $115
- Roblox (RBLX) – MoffettNathanson – Sell>>Neutral – $26
- Relay Therapeutics (RLAY) – Barclays – Equal Weight>>Overweight – $15
- Squarespace (SQSP) – Mizuho – Neutral>>Buy – $34>>$50
- TPG Inc. (TPG) – Morgan Stanley – Equal-Weight>>Overweight – $43>>$52
- Warner Bros. Discovery (WBD) – KeyBanc Capital Markets – Sector Weight>>Overweight – $11
- Tower Semi (TSEM) – Susquehanna – Neutral>>Positive – $36>>$55
- Novavax (NVAX) – JP Morgan – Underweight>>Neutral
- Bilibili (BILI) – CLSA – Outperform>>Buy
- Novavax (NVAX) – BofA Securities – Underperform>>Neutral – $4>>$12
- Downgrades:
- Baxter (BAX) – TD Cowen – Buy>>Hold – $40
- Collegium Pharmaceutical (COLL) – Piper Sandler – Overweight>>Neutral – $39
- Cerence (CRNC) – Wells Fargo – Overweight>>Equal Weight – $25>>$6.5
- Ginkgo Bioworks (DNA) – William Blair – Mkt Perform>>Underperform
- EPAM Systems (EPAM) – Scotiabank – Sector Outperform>>Sector Perform – $245
- Globant (GLOB) – Scotiabank – Sector Outperform>>Sector Perform – $200
- MacroGenics (MGNX) – TD Cowen – Buy>>Hold
- MacroGenics (MGNX) – Stifel – Buy>>Hold – $29>>$7
- MacroGenics (MGNX) – BMO Capital Markets – Outperform>>Market Perform – $24>>$8
- Progyny (PGNY) – KeyBanc Capital Markets – Overweight>>Sector Weight
- Planet Fitness (PLNT) – Stifel – Buy>>Hold – $80>>$70
- PennantPark Investment (PNNT) – Raymond James – Outperform>>Mkt Perform
- RAPT Therapeutics (RAPT) – Barclays – Overweight>>Equal Weight – $13>>$4
- RAPT Therapeutics (RAPT) – Guggenheim – Buy>>Neutral
- Ready Capital (RC) – Ladenburg Thalmann – Buy>>Neutral
- Safehold (SAFE) – Mizuho – Buy>>Neutral – $22>>$20
- TELUS International (TIXT) – Scotiabank – Sector Outperform>>Sector Perform – $10
- Vital Farms (VITL) – Stifel – Buy>>Hold – $30>>$40
- Light & Wonder (LNW) – Susquehanna – Positive>>Neutral – $111>>$95
- Collegium Pharmaceutical (COLL) – Needham – Buy>>Hold
- Evolv Technologies Holdings (EVLV) – Lake Street – Buy>>Hold – $6>>$3.5
- Vista Outdoor (VSTO) – Lake Street – Buy>>Hold – $33>>$37
- Coverage Initiated:
- Apogee Therapeutics (APGE) – BofA Securities – Buy – $80
- Aquestive Therapeutics (AQST) – Leerink Partners – Outperform – $8
- Soleno Therapeutics (SLNO) – Robert W. Baird – Outperform – $72
- Sow Good (SOWG) – ROTH MKM – Buy – $15
- Sow Good (SOWG) – Craig Hallum – Buy – $20
- Solventum Corporation (SOLV) – BofA Securities – Neutral – $70
Thursday, May 9th:
Upgrades:
- Cheesecake Factory (CAKE)
- Brokerage Firm: Raymond James
- Ratings Change: Mkt Perform >> Outperform
- Price Target: $42
- Editas Medicine (EDIT)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Underweight >> Equal-Weight
- Price Target: $7
- Emerson (EMR)
- Brokerage Firm: Deutsche Bank
- Ratings Change: Hold >> Buy
- Price Target: $123 >> $138
- EVgo Inc. (EVGO)
- Brokerage Firm: Cantor Fitzgerald
- Ratings Change: Neutral >> Overweight
- Price Target: $5 >> $4
- Fox Corporation (FOXA)
- Brokerage Firm: BofA Securities
- Ratings Change: Neutral >> Buy
- Price Target: $34 >> $40
- LL Flooring Holdings (LL)
- Brokerage Firm: Loop Capital
- Ratings Change: Sell >> Hold
- Price Target: $2
- Live Nation (LYV)
- Brokerage Firm: Redburn Atlantic
- Ratings Change: Neutral >> Buy
- Price Target: $114 >> $115
- Shopify (SHOP)
- Brokerage Firm: JMP Securities
- Ratings Change: Mkt Perform >> Mkt Outperform
- Price Target: $80
- Shopify (SHOP)
- Brokerage Firm: Piper Sandler
- Ratings Change: Underweight >> Neutral
- Price Target: $63
- Select Water Solutions (WTTR)
- Brokerage Firm: Citigroup
- Ratings Change: Neutral >> Buy
- Price Target: $13
- CytomX Therapeutics (CTMX)
- Brokerage Firm: Wedbush
- Ratings Change: Neutral >> Outperform
- Price Target: $8
- Manulife Financial (MFC)
- Brokerage Firm: National Bank Financial
- Ratings Change: Sector Perform >> Outperform
- Affirm (AFRM)
- Brokerage Firm: JP Morgan
- Ratings Change: Neutral >> Overweight
- Price Target: $41 >> $43
Downgrades:
- DoubleVerify (DV)
- Brokerage Firm: BofA Securities
- Ratings Change: Buy >> Underperform
- Price Target: $45 >> $18
- Enhabit Inc. (EHAB)
- Brokerage Firm: Jefferies
- Ratings Change: Buy >> Hold
- Price Target: $14 >> $8.75
- Skyworks (SWKS)
- Brokerage Firm: Wolfe Research
- Ratings Change: Outperform >> Peer Perform
- TripAdvisor (TRIP)
- Brokerage Firm: DA Davidson
- Ratings Change: Buy >> Neutral
- Price Target: $31 >> $20
- Viridian Therapeutics (VRDN)
- Brokerage Firm: B. Riley Securities
- Ratings Change: Buy >> Neutral
- Price Target: $25 >> $20
- SolarEdge Technologies (SEDG)
- Brokerage Firm: Northland Capital
- Ratings Change: Outperform >> Market Perform
- Viridian Therapeutics (VRDN)
- Brokerage Firm: Ladenburg Thalmann
- Ratings Change: Buy >> Neutral
- Louisiana-Pacific (LPX)
- Brokerage Firm: Seaport Research Partners
- Ratings Change: Buy >> Neutral
- Airbnb (ABNB)
- Brokerage Firm: HSBC Securities
- Ratings Change: Buy >> Hold
- Price Target: $160 >> $156
Coverage Initiated:
- Perspective Therapeutics (CATX)
- Brokerage Firm: Cantor Fitzgerald
- Ratings Change: Overweight
- DiaSorin S.p.A. (DSRLF)
- Brokerage Firm: Barclays
- Ratings Change: Equal Weight
- ArcelorMittal (MT)
- Brokerage Firm: Goldman
- Ratings Change: Neutral
- Barclays PLC (BCS)
- Brokerage Firm: Deutsche Bank
- Ratings Change: Buy
- Lloyds Banking (LYG)
- Brokerage Firm: Deutsche Bank
- Ratings Change: Buy
Wednesday, May 8th:
Upgrades:
- Alignment Healthcare (ALHC)
- Brokerage Firm: Piper Sandler
- Ratings Change: Neutral >> Overweight
- Price Target: $6 >> $8
- Datadog (DDOG)
- Brokerage Firm: Robert W. Baird
- Ratings Change: Neutral >> Outperform
- Price Target: $130 >> $140
- Energizer (ENR)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Underweight >> Equal-Weight
- Price Target: $33
- Envestnet (ENV)
- Brokerage Firm: Jefferies
- Ratings Change: Underperform >> Hold
- Price Target: $47 >> $59
- HireRight Holdings (HRT)
- Brokerage Firm: William Blair
- Ratings Change: Mkt Perform >> Outperform
- Hexcel (HXL)
- Brokerage Firm: Wells Fargo
- Ratings Change: Equal Weight >> Overweight
- Price Target: $81 >> $95
- Intl Flavors (IFF)
- Brokerage Firm: JP Morgan
- Ratings Change: Neutral >> Overweight
- Price Target: $75 >> $100
- Nutanix (NTNX)
- Brokerage Firm: Raymond James
- Ratings Change: Mkt Perform >> Outperform
- Price Target: $72
- Old Dominion (ODFL)
- Brokerage Firm: Robert W. Baird
- Ratings Change: Neutral >> Outperform
- Price Target: $205
- Orthofix (OFIX)
- Brokerage Firm: ROTH MKM
- Ratings Change: Neutral >> Buy
- Price Target: $15 >> $20
- Boston Beer Co (SAM)
- Brokerage Firm: Deutsche Bank
- Ratings Change: Sell >> Hold
- Price Target: $273
- Confluent (CFLT)
- Brokerage Firm: Canaccord Genuity
- Ratings Change: Hold >> Buy
- Price Target: $35
- Crexendo (CXDO)
- Brokerage Firm: B. Riley Securities
- Ratings Change: Neutral >> Buy
- Price Target: $6.75 >> $5.75
- ExlService (EXLS)
- Brokerage Firm: Wedbush
- Ratings Change: Neutral >> Outperform
- Price Target: $34 >> $40
- Redfin (RDFN)
- Brokerage Firm: Stephens
- Ratings Change: Equal-Weight >> Overweight
- Price Target: $8 >> $9
- ADTRAN (ADTN)
- Brokerage Firm: Northland Capital
- Ratings Change: Market Perform >> Outperform
- Price Target: $7.5
- Myriad Genetics (MYGN)
- Brokerage Firm: Leerink Partners
- Ratings Change: Market Perform >> Outperform
- Price Target: $25 >> $35
- SK Telecom (SKM)
- Brokerage Firm: Nomura
- Ratings Change: Reduce >> Neutral
Downgrades:
- Definitive Healthcare (DH)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Overweight >> Equal-Weight
- Price Target: $11.5 >> $9
- DoubleVerify (DV)
- Brokerage Firm: KeyBanc Capital Markets
- Ratings Change: Overweight >> Sector Weight
- Golub Capital (GBDC)
- Brokerage Firm: Raymond James
- Ratings Change: Outperform >> Mkt Perform
- WK Kellogg Co (KLG)
- Brokerage Firm: Exane BNP Paribas
- Ratings Change: Neutral >> Underperform
- Price Target: $20
- NASDAQ (NDAQ)
- Brokerage Firm: Rosenblatt
- Ratings Change: Buy >> Neutral
- Price Target: $76 >> $64
- Nuvei Corporation (NVEI)
- Brokerage Firm: JP Morgan
- Ratings Change: Overweight >> Neutral
- Price Target: $32 >> $34
- Premier (PINC)
- Brokerage Firm: Canaccord Genuity
- Ratings Change: Buy >> Hold
- Price Target: $27 >> $21
- Runway Growth Finance (RWAY)
- Brokerage Firm: Compass Point
- Ratings Change: Buy >> Neutral
- Price Target: $12.75
- Rhythm Pharmaceuticals (RYTM)
- Brokerage Firm: BofA Securities
- Ratings Change: Buy >> Neutral
- Price Target: $49 >> $42
- Saratoga Investment (SAR)
- Brokerage Firm: Oppenheimer
- Ratings Change: Outperform >> Perform
- Shoals Technologies (SHLS)
- Brokerage Firm: ROTH MKM
- Ratings Change: Buy >> Neutral
- Price Target: $15 >> $8
- Treace Medical Concepts (TMCI)
- Brokerage Firm: BTIG Research
- Ratings Change: Buy >> Neutral
- Treace Medical Concepts (TMCI)
- Brokerage Firm: JP Morgan
- Ratings Change: Overweight >> Neutral
- Price Target: $15 >> $8
- Vishay Precision (VPG)
- Brokerage Firm: B. Riley Securities
- Ratings Change: Buy >> Neutral
- Price Target: $37 >> $36
- Victoria’s Secret (VSCO)
- Brokerage Firm: Barclays
- Ratings Change: Equal Weight >> Underweight
- Price Target: $14
- WideOpenWest (WOW)
- Brokerage Firm: Raymond James
- Ratings Change: Outperform >> Mkt Perform
- ZoomInfo (ZI)
- Brokerage Firm: Goldman
- Ratings Change: Neutral >> Sell
- Price Target: $19.5 >> $12
- ZoomInfo (ZI)
- Brokerage Firm: Piper Sandler
- Ratings Change: Overweight >> Neutral
- Price Target: $24 >> $15
- Treace Medical Concepts (TMCI)
- Brokerage Firm: Stifel
- Ratings Change: Buy >> Hold
- Price Target: $15 >> $6
- ZoomInfo (ZI)
- Brokerage Firm: Mizuho
- Ratings Change: Buy >> Neutral
- Price Target: $23
Coverage Initiated:
- Sutro Biopharma (STRO):
- Brokerage Firm: BofA Securities
- Ratings Change: Buy
- Price Target: $12
- Advanced Drainage Systems (WMS):
- Brokerage Firm: Northcoast
- Ratings Change: Buy
- Price Target: $190
Tuesday, May 7th:
Upgrades
- Advanced Micro (AMD)
- Brokerage Firm: DZ Bank
- Ratings Change: Hold >> Buy
- Price Target: $190
- Design Therapeutics (DSGN)
- Brokerage Firm: Piper Sandler
- Ratings Change: Neutral >> Overweight
- Price Target: $6 >> $12
- Gap (GPS)
- Brokerage Firm: Citigroup
- Ratings Change: Neutral >> Buy
- Price Target: $21 >> $28
- Cloudflare (NET)
- Brokerage Firm: DZ Bank
- Ratings Change: Hold >> Buy
- Price Target: $95
- Omnicom (OMC)
- Brokerage Firm: Barclays
- Ratings Change: Equal Weight >> Overweight
- Price Target: $100 >> $110
- Philips (PHG)
- Brokerage Firm: Exane BNP Paribas
- Ratings Change: Underperform >> Neutral
- Insulet (PODD)
- Brokerage Firm: Wolfe Research
- Ratings Change: Peer Perform >> Outperform
- Price Target: $200
- Sunstone Hotel (SHO)
- Brokerage Firm: Compass Point
- Ratings Change: Sell >> Neutral
- Price Target: $10 >> $12
- Target (TGT)
- Brokerage Firm: Citigroup
- Ratings Change: Neutral >> Buy
- Price Target: $180
- Ubisoft (UBSFY)
- Brokerage Firm: Stifel
- Ratings Change: Hold >> Buy
- Vale S.A. (VALE)
- Brokerage Firm: UBS
- Ratings Change: Neutral >> Buy
- Price Target: $13 >> $15
- Cognex (CGNX)
- Brokerage Firm: HSBC Securities
- Ratings Change: Hold >> Buy
Downgrades
- CVS Health (CVS)
- Brokerage Firm: TD Cowen
- Ratings Change: Buy >> Hold
- Price Target: $99 >> $59
- Integra (IART)
- Brokerage Firm: Wells Fargo
- Ratings Change: Overweight >> Equal Weight
- Price Target: $45 >> $25
- Lyra Therapeutics (LYRA)
- Brokerage Firm: BofA Securities
- Ratings Change: Buy >> Underperform
- Lyra Therapeutics (LYRA)
- Brokerage Firm: Jefferies
- Ratings Change: Buy >> Hold
- Price Target: $10 >> $0.5
- Lyra Therapeutics (LYRA)
- Brokerage Firm: H.C. Wainwright
- Ratings Change: Buy >> Neutral
- Price Target: $12 >> $2
- Teradata (TDC)
- Brokerage Firm: BofA Securities
- Ratings Change: Neutral >> Underperform
- Price Target: $48 >> $39
- Vestis (VSTS)
- Brokerage Firm: Redburn Atlantic
- Ratings Change: Buy >> Neutral
- Price Target: $13.4
- Integra (IART)
- Brokerage Firm: Oppenheimer
- Ratings Change: Outperform >> Perform
Coverage Initiated
- Corning (GLW)
- Brokerage Firm: Mizuho
- Ratings Change: Neutral
- Price Target: $36
- Metagenomi (MGX)
- Brokerage Firm: H.C. Wainwright
- Ratings Change: Buy
- Price Target: $10
- Summit Therapeutics (SMMT)
- Brokerage Firm: Citigroup
- Ratings Change: Buy
- Price Target: $7
- UL Solutions Inc. (ULS)
- Brokerage Firm: BofA Securities
- Ratings Change: Buy
- Price Target: $42
- UL Solutions Inc. (ULS)
- Brokerage Firm: Wells Fargo
- Ratings Change: Overweight
- Price Target: $40
- UL Solutions Inc. (ULS)
- Brokerage Firm: Citigroup
- Ratings Change: Buy
- Price Target: $41
- UL Solutions Inc. (ULS)
- Brokerage Firm: Stifel
- Ratings Change: Buy
- Price Target: $40
- UL Solutions Inc. (ULS)
- Brokerage Firm: JP Morgan
- Ratings Change: Overweight
- Price Target: $39
- UL Solutions Inc. (ULS)
- Brokerage Firm: Robert W. Baird
- Ratings Change: Outperform
- Price Target: $40
- UL Solutions Inc. (ULS)
- Brokerage Firm: Jefferies
- Ratings Change: Buy
- Price Target: $42
- UL Solutions Inc. (ULS)
- Brokerage Firm: UBS
- Ratings Change: Neutral
- Price Target: $38
- UL Solutions Inc. (ULS)
- Brokerage Firm: Goldman
- Ratings Change: Neutral
- Price Target: $39
- UL Solutions Inc. (ULS)
- Brokerage Firm: Raymond James
- Ratings Change: Outperform
- Price Target: $42
- UL Solutions Inc. (ULS)
- Brokerage Firm: William Blair
- Ratings Change: Outperform
- Ares Management (ARES)
- Brokerage Firm: TD Cowen
- Ratings Change: Buy
- Price Target: $154
- LanzaTech (LNZA)
- Brokerage Firm: TD Cowen
- Ratings Change: Hold
- Price Target: $3
Monday, May 6th:
Upgrades
- Bausch + Lomb (BLCO)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Equal-Weight >> Overweight
- Price Target: $16 >> $18
- Blueprint Medicines (BPMC)
- Brokerage Firm: Leerink Partners
- Ratings Change: Underperform >> Market Perform
- Price Target: $50 >> $97
- Banco Santander Brasil (BSBR)
- Brokerage Firm: BofA Securities
- Ratings Change: Neutral >> Buy
- Camden Property (CPT)
- Brokerage Firm: Piper Sandler
- Ratings Change: Underweight >> Neutral
- Price Target: $90 >> $110
- CytomX Therapeutics (CTMX)
- Brokerage Firm: Jefferies
- Ratings Change: Hold >> Buy
- Price Target: $2.5 >> $8
- Glaukos (GKOS)
- Brokerage Firm: Jefferies
- Ratings Change: Hold >> Buy
- Price Target: $84 >> $125
- Mid-America Aptmt (MAA)
- Brokerage Firm: Wedbush
- Ratings Change: Neutral >> Outperform
- Price Target: $135 >> $154
- Melco Resorts & Entertainment (MLCO)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Equal-Weight >> Overweight
- Price Target: $8.3 >> $9.6
- Micron (MU)
- Brokerage Firm: Robert W. Baird
- Ratings Change: Neutral >> Outperform
- Price Target: $115 >> $150
- Silicon Motion (SIMO)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Equal-Weight >> Overweight
- Price Target: $59 >> $88
- Sensata Tech (ST)
- Brokerage Firm: Evercore ISI
- Ratings Change: In-line >> Outperform
- Price Target: $44 >> $60
- Wolverine (WWW)
- Brokerage Firm: Seaport Research Partners
- Ratings Change: Neutral >> Buy
- Price Target: $15
- U.S. Steel (X)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Equal-Weight >> Overweight
- Price Target: $51 >> $48
- Chemomab Therapeutics (CMMB)
- Brokerage Firm: Oppenheimer
- Ratings Change: Perform >> Outperform
- Price Target: $6
- ModivCare (MODV)
- Brokerage Firm: Lake Street
- Ratings Change: Hold >> Buy
- Price Target: $50
Downgrades
- Comerica (CMA)
- Brokerage Firm: Citigroup
- Ratings Change: Buy >> Neutral
- Price Target: $56
- Johnson Controls (JCI)
- Brokerage Firm: UBS
- Ratings Change: Buy >> Neutral
- Price Target: $74 >> $68
- Peloton (PTON)
- Brokerage Firm: Citigroup
- Ratings Change: Buy >> Neutral
- Price Target: $8 >> $4
- Ryan Specialty Group (RYAN)
- Brokerage Firm: Wolfe Research
- Ratings Change: Outperform >> Peer Perform
- Victoria’s Secret (VSCO)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Equal-Weight >> Underweight
- Price Target: $19 >> $15
- Uniti Group (UNIT)
- Brokerage Firm: Raymond James
- Ratings Change: Strong Buy >> Outperform
- Price Target: $8 >> $6
- Carpenter Tech (CRS)
- Brokerage Firm: Northcoast
- Ratings Change: Buy >> Neutral
- Daqo New Energy (DQ)
- Brokerage Firm: HSBC Securities
- Ratings Change: Hold >> Reduce
- Price Target: $23.5 >> $17.5
- LuxUrban Hotels (LUXH)
- Brokerage Firm: Northland Capital
- Ratings Change: Outperform >> Market Perform
- Lyra Therapeutics (LYRA)
- Brokerage Firm: William Blair
- Ratings Change: Outperform >> Mkt Perform
Coverage Initiated
- EHang (EH)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Overweight
- Price Target: $27.5
- enCore Energy Corp. (EU)
- Brokerage Firm: H.C. Wainwright
- Ratings Change: Buy
- Price Target: $7.5
- Flutter Entertainment (FLUT)
- Brokerage Firm: MoffettNathanson
- Ratings Change: Buy
- Price Target: $240
- Jasper Therapeutics (JSPR)
- Brokerage Firm: H.C. Wainwright
- Ratings Change: Buy
- Price Target: $65
- PACS Group (PACS)
- Brokerage Firms: RBC Capital Mkts, Truist, Oppenheimer, Citigroup, JP Morgan, Stephens
- Ratings Change: Outperform, Buy, Outperform, Buy, Overweight, Overweight
- Price Targets: $30, $32, $31, $32, $27, $31
- Eton Pharmaceuticals (ETON)
- Brokerage Firm: Craig Hallum
- Ratings Change: Buy
- Price Target: $8
